If we could examine the downstream effect of CXCR1 compared to CXCR2 when bound to CXCL8 or CXCL6, we could evaluate which downstream pathways elicit pro-CSC-like characteristics in the tumor cells. The gene discussed is CXCR2; the disease is neoplasm.